TYPE 1 DIABETES – COMPLICATIONS, PATHOGENESIS, AND ALTERNATIVE TREATMENTS docx
TYPE 1 DIABETES – COMPLICATIONS, PATHOGENESIS, AND ALTERNATIVE TREATMENTS docx
... (nmol/ml) 10 0(88, 11 0) 10 10 6 (10 5, 16 1) 19 12 7 (10 9, 15 2)
a
17
TGF-beta1 (
n
g
/ml) 3.30 ± 3. 41 8 5.9 ± 4 .14
b
10 10 .49 ± 4.55
a
16
VCAM -1 (n
g
/ml) 12 .6 ± 3.7 15 17 .1 ± 3 .1 19 17 .4 ± 3.3
a
... 9.0(6 .1, 14.0) 26 14 .4 (12 .4, 17 .9)
ab
20 16 .4 (15 .1, 17 .6)
a
26
DD (
y
rs.) - 0 6(5.5, 8 .1)
b
20 10 .0(7.9, 12 .9) 26
HbA1cA (%) 5.0 ± 0.3...
TYPE 1 DIABETES COMPLICATIONS ppt
...
Control
OR
ACE
17 q23
rs179975 D
14 2 215 /2685 1. 13
AKR1B1
7q35
(AC)n repeat Z-2
10 13 80 /13 08 1. 12
(AC)n repeat Z+2
10 13 80 /13 08 0.79
rs759853 T
4 636/537 1. 58
APOC1
19 q13.2
rs4420638 ...
2 857/935 1. 54
APOE
19 q13.2
E2/E3/E4 E2
6 889/803 1. 48
EPO
7q 21
rs1 617 640 T
2 12 44/ 715 0.67
GREM1
15 q13-q15
rs 112 9456 T
2 859/940 1. 53
HSPG2
1...
báo cáo hóa học:" The cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients’ conceptions of type 1 diabetes" pot
... (0.64 - 1. 15)
Diabetes duration, years 1. 10 (1. 07 - 1. 13) 1. 04 (1. 01 - 1. 06) 1. 12 (1. 09 - 1. 15) 1. 11 (1. 08 - 1. 13) 0.99 (0.98 - 1. 01)
Age at onset, years 1. 00 (0.94 - 1. 03) 0.95 (0.92 - 0.99) 1. 00 ... NA 0.83 (0.64 - 1. 08)
Diabetes duration, years 1. 07 (1. 05 - 1. 09) 1. 04 (1. 02 - 1. 06) 1. 11 (1. 09 - 1. 13) 1. 10 (1. 08 - 1. 12) 0.99 (0.98...
TYPE 1 DIABETES – PATHOGENESIS, GENETICS AND IMMUNOTHERAPY ppt
...
(Baltimore, Md.: 19 50), (March 19 97), Vol .15 8, No.5, pp. 2 414 -2424, ISSN 0022 -17 67
Autoimmunity and Immunotherapy of Type 1 Diabetes
7
located on chromosome 2q 31. 1 and chromosome 10 p 11. 23, respectively ... New
England Journal of Medicine, (March 19 88), Vol. 318 , No .11 , pp. 66 3–6 70, ISSN 0028-
4793
Type 1 Diabetes – Pathogenesis, Genetics...
Prevalence of Celiac disease in Turkish children with type 1 Diabetes Mellitus and their non-diabetic first-degree relatives pptx
... offspring (824) 1. 9 (16 ) 1. 9 (16 ) <0.0 01
Control (4000) 0.25 (10 ) 0.25 (10 )
Williams et al. IgA-AEA; IgA-tTG Diabetic children (433) 13 .4 (58)
20 01 UK (10 ) Parent (8 71) and sibling (5 71) 7 (10 0) <0.05
Control ... (24) 16 .4 (19 )
19 96 Algeria (13 ) Biopsy Relatives (3 81) 6.8 (26) 3.4 (13 )
Hummel et al. AEA, IgA&IgG-AGA Diabetic parents (99) 10 .1
2000 Germ...
báo cáo hóa học:" Health related quality of life of Iranian children with type 1 diabetes: reliability and validity of the Persian version of the PedsQL Generic Core Scales and Diabetes Module" pot
...
66.65
19 .24
0.72
200
73 .12
20.68
5. 61
(1,
292
)
0. 01
9
Psychosocial health
15
94
66. 81
13 . 81
0.79
200
74 .15
16 .59
12 .13
(1,
292
)
0.0 01
PedsQL
TM
... of
children with type 1 diabetes mellitus (T1DM): self and parental perceptions. Pediatr
Diabetes 2 011 , 12 (1) :34-40.
2. Pishdad GR: Low incidence of...
Complementary and Alternative Treatments in Mental Health Care doc
... Complement Ther
Med 6 :14 1 14 3, 19 98
Unutzer J, Klap R, Sturm R, et al: Mental disorders and the use of alternative medicine:
results from a national survey. Am J Psychiatry 15 7 :18 51 18 57, 2000
Verhoef ... the wisdom? BMJ 303:79 8–7 99, 19 91
Sparber A, Wootton JC: Surveys of complementary and alternative medicine, V: use of
alternative and complementary therapies for...
Type 1 Diabetes Clinical Management of the Athlete potx
... hyperketonemia and hyper-
lacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone
responses during hypoglycemia in normal humans. Diabetes. 19 94;43 :13 11 7.
11
1 Endocrine and ... supply and demand. Am J Physiol.
19 94;267:E 411 – 21.
13 0. Niijima A. Glucose-sensitive afferent nerve fi bres in the hepatic branch of the vagus nerve in
the guine...
Từ khóa:
- the role of newer technologies csii and cgm and novel strategies in the management of type 1 diabetes for sport and exercise
- type 1 diabetes and heart attack risk
- type 1 diabetes and stem cells a new approach
- immunotherapy of type 1 diabetes immunoprevention and immunoreversal
- young women with type 1 diabetes apos management of turning points and transitions
- adherence metabolic control and quality of life in adolescents with type 1 diabetes
- induction of tolerance using apoptotic cells in type 1 diabetes and other immune mediated disorders
- proteins a family of secreted c type lectins in islet regeneration and as autoantigens in type 1 diabetes
- epidemics autoimmunity and type 1 diabetes